161 related articles for article (PubMed ID: 25749387)
1. The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer.
Zheng G; Jia X; Peng C; Deng Y; Yin J; Zhang Z; Li N; Deng M; Liu X; Liu H; Lu M; Wang C; Gu Y; He Z
Oncotarget; 2015 Mar; 6(9):6931-43. PubMed ID: 25749387
[TBL] [Abstract][Full Text] [Related]
2. MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer.
Zheng G; Li N; Jia X; Peng C; Luo L; Deng Y; Yin J; Song Y; Liu H; Lu M; Zhang Z; Gu Y; He Z
J Mol Med (Berl); 2016 Oct; 94(10):1129-1141. PubMed ID: 27055844
[TBL] [Abstract][Full Text] [Related]
3. The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.
Chen HH; Huang WT; Yang LW; Lin CW
Am J Pathol; 2015 May; 185(5):1487-99. PubMed ID: 25907832
[TBL] [Abstract][Full Text] [Related]
4. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.
Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM
J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
6. miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN.
Zhao M; Luo R; Liu Y; Gao L; Fu Z; Fu Q; Luo X; Chen Y; Deng X; Liang Z; Li X; Cheng C; Liu Z; Fang W
Nat Commun; 2016 Apr; 7():11309. PubMed ID: 27095304
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
[TBL] [Abstract][Full Text] [Related]
8. IKK interacts with rictor and regulates mTORC2.
Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
[TBL] [Abstract][Full Text] [Related]
9. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
Tripathy S; Jump DB
J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
[TBL] [Abstract][Full Text] [Related]
10. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
[TBL] [Abstract][Full Text] [Related]
11. microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells.
Cui Y; Zhao J; Yi L; Jiang Y
PLoS One; 2016; 11(6):e0156915. PubMed ID: 27295037
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT
Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727
[TBL] [Abstract][Full Text] [Related]
13. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
[TBL] [Abstract][Full Text] [Related]
14. Mdm20 Modulates Actin Remodeling through the mTORC2 Pathway via Its Effect on Rictor Expression.
Yasuda K; Takahashi M; Mori N
PLoS One; 2015; 10(11):e0142943. PubMed ID: 26600389
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.
Wang RH; Kim HS; Xiao C; Xu X; Gavrilova O; Deng CX
J Clin Invest; 2011 Nov; 121(11):4477-90. PubMed ID: 21965330
[TBL] [Abstract][Full Text] [Related]
16. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.
Guertin DA; Stevens DM; Thoreen CC; Burds AA; Kalaany NY; Moffat J; Brown M; Fitzgerald KJ; Sabatini DM
Dev Cell; 2006 Dec; 11(6):859-71. PubMed ID: 17141160
[TBL] [Abstract][Full Text] [Related]
17. Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.
Masui K; Tanaka K; Ikegami S; Villa GR; Yang H; Yong WH; Cloughesy TF; Yamagata K; Arai N; Cavenee WK; Mischel PS
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9406-11. PubMed ID: 26170313
[TBL] [Abstract][Full Text] [Related]
18. MiR-424/503-mediated Rictor upregulation promotes tumor progression.
Oneyama C; Kito Y; Asai R; Ikeda J; Yoshida T; Okuzaki D; Kokuda R; Kakumoto K; Takayama K; Inoue S; Morii E; Okada M
PLoS One; 2013; 8(11):e80300. PubMed ID: 24244675
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells
Zheng B; Wang J; Tang L; Tan C; Zhao Z; Xiao Y; Ge R; Zhu D
Int J Biol Sci; 2017; 13(1):110-121. PubMed ID: 28123351
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1.
Brown J; Wang H; Suttles J; Graves DT; Martin M
J Biol Chem; 2011 Dec; 286(52):44295-305. PubMed ID: 22045807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]